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introduction: Radiation therapy for lung cancer causes pneumonitis and fibrosis. Soy 
isoflavones protect against radiation-induced lung injury, but the mediators of radio-
protection remain unclear. We investigated the effect of radiation on myeloid-derived 
suppressor cells (MDSCs) in the lung and their modulation by soy isoflavones for a 
potential role in protection from radiation-induced lung injury.
Methods: BALB/c mice (5–6 weeks old) received a single 10 Gy dose of thoracic irra-
diation and soy isoflavones were orally administrated daily before and after radiation at 
1 mg/day. Arginase-1 (Arg-1) and nuclear factor κB (NF-κB) p65 were detected in lung 
tissue by western blot analysis and immunohistochemistry. Lung MDSC subsets and 
their Arg-1 expression were analyzed by flow cytometry. Cytokine levels in the lungs 
were measured by ELISA.
results: At 1  week after radiation, CD11b+ cells expressing Arg-1 were decreased 
by radiation in lung tissue yet maintained in the lungs treated with radiation and soy 
isoflavones. Arg-1 was predominantly expressed by CD11b+Ly6ClowLy6G+ granulocytic 
MDSCs (gr-MDSCs). Arg-1 expression in gr-MDSCs was reduced by radiation and 
preserved by supplementation with soy isoflavones. A persistent increase in Arg-1+ cells 
was observed in lung tissue treated with combined radiation and soy isoflavones at early 
and late time points, compared to radiation alone. The increase in Arg-1 expression 
mediated by soy isoflavones could be associated with the inhibition of radiation-induced 
activation of NF-κB and the control of pro-inflammatory cytokine production demon-
strated in this study.
conclusion: A radioprotective mechanism of soy isoflavones may involve the promotion 
of Arg-1-expressing gr-MDSCs that could play a role in downregulation of inflammation 
and lung radioprotection.
Keywords: radiation, soy isoflavones, lung inflammation, MDscs, arginase-1
inTrODUcTiOn
Non-small cell lung cancer (NSCLC) represents 85% of lung cancers, and the treatment of 
advanced disease remains a major clinical challenge (1, 2). Unresectable, stage III NSCLC is 
diagnosed in 50,000 Americans annually and is currently treated by concurrent chemoradiation 
therapy with a 5-year survival rate of only 20% (1, 2). The overall dose of radiation is limited by 
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lung tissue toxicity presenting as radiation pneumonitis in up 
to 30% of NSCLC patients, necessitating means to improve the 
therapeutic ratio (3, 4).
Radiation pneumonitis is caused by an early inflammatory 
process triggered by tissue damage to lung parenchyma, epithelial 
cells, vascular endothelial cells, and stroma. This process induces 
the expression of pro-inflammatory cytokines and chemokines, 
which drive the recruitment of inflammatory cells into the injured 
tissue (5–7). Infiltrating inflammatory cells contribute to cyclical 
cytokine cascades responsible for clinical pneumonitis and late 
fibrosis (8, 9).
We have previously demonstrated that soy isoflavones protect 
against radiation-induced pneumonitis and fibrosis in naïve mice 
and xenografted lung tumor-bearing mice (10–12). In naïve mice, 
soy isoflavones given preradiation and postradiation reduced 
radiation injury to skin and hair follicles, protected respiratory 
function, and decreased inflammatory infiltrates and fibrosis 
(12). Significant decreases in pneumonitis, vascular damage, and 
fibrosis were also observed in lung tumor-bearing mice treated 
with soy isoflavones and radiation (10, 11). Furthermore, soy 
isoflavones differentially affected tumor versus lung tissue by 
radiosensitizing tumor nodules while radioprotecting normal 
lung tissue (11). We also recently reported that soy isoflavones 
reduced the extent of esophagitis caused by radiation within 
esophageal submucosal tissue layers (13). These findings suggest 
that soy isoflavones act in preventing inflammatory events in 
normal tissues within the field of thoracic irradiation. Recent 
efforts to determine modulation of inflammation by soy iso-
flavones revealed inhibition of the persistent infiltration and 
activation of macrophages and neutrophils at late time points of 
12 and 18 weeks caused by radiation in the lungs (14). However, 
early immunosuppressive mediators of radioprotection by soy 
isoflavones remain to be identified.
To investigate the early events associated with soy isoflavone 
radioprotection, we have now studied immunosuppressive cells 
and molecules that could control the extent of inflammatory 
processes induced by radiation. Myeloid-derived suppressor cells 
(MDSCs) have been found to regulate inflammation induced by 
injury, pathogens, inflammatory diseases, and cancer (15, 16). 
MDSCs are a heterogeneous population of early myeloid pro-
genitors, immature granulocytes, macrophages, and dendritic 
cells at different stages of differentiation (15, 17). Murine MDSCs 
express high levels of the CD11b myeloid lineage marker and the 
Gr-1 granulocytic marker. Gr-1 refers to two cell membrane mol-
ecules, Ly6C and Ly6G, and murine MDSCs are further classified 
into two subtypes, monocytic and granulocytic, according to 
their relative expression level. Monocytic MDSCs (mo-MDSCs) 
express high levels of Ly6C and low or no expression of Ly6G 
marker; granulocytic MDSCs (gr-MDSCs) express low levels of 
Ly6C and high levels of Ly6G (15, 17). MDSCs act by suppressing 
the function of lymphocytes including T cells, natural killer cells, 
and macrophages. Their immunosuppressive action is primarily 
mediated by affecting the metabolism of l-arginine, a common 
catalyzing substrate of NOS and arginase (15, 17). Arginase is 
an enzyme of the urea cycle that converts l-arginine to urea 
and exists as two isoforms: arginase 1 (Arg-1) and arginase 2 
(Arg-2) (18). Arg-1 is associated with chronic inflammatory 
diseases, such as asthma and inflammatory bowel disease (19, 
20). Arg-1 contributes to immune deactivation and is involved 
in inflammatory responses to LPS and pathogens (21, 22). Arg-1 
can also reduce the activity of reactive oxygen species (ROS). 
Arg-1 expression by MDSCs could interfere with ROS induced 
by radiation that are involved in activation of nuclear factor 
κB (NF-κB) and transcription of inflammatory cytokines and 
chemokines (15, 22). In the current study, we have investigated 
whether Arg-1 expression in MDSCs could play a role in the 
decreased inflammation caused by soy isoflavones in irradiated 
lungs.
The effect of soy isoflavones on the expression of Arg-1 by 
MDSCs subsets in lung tissues was evaluated at early and late 
time points after radiation. Molecular events associated with 
Arg-1 expression involving NF-κB and inflammatory cytokines 
were also studied. Our findings suggest that high levels of 
Arg-1 expression by gr-MDSCs in the lungs are decreased by 
radiation but protected by soy isoflavones. The protection of 
Arg-1-positive immunosuppressive MDSCs by soy isoflavones 
could be associated with inhibition of radiation-induced NF-κB 
and inflammatory cytokines as a part of the radioprotection 
mechanisms.
MaTerials anD MeThODs
Mice
Female BALB/c mice (Harlan, Indianapolis, IN, USA) of 
5–6  weeks old were housed and handled in animal facilities 
accredited by the Association for Assessment and Accreditation 
of Laboratory Animal Care. The animal protocol was approved 
by Wayne State University Institutional Animal Care and Use 
Committee.
soy isoflavones
The soy isoflavone mixture G-4660 used is a pure extract of 
98.16% isoflavones from soybeans consisting of 83.3% genistein, 
14.6% daidzein, and 0.26% glycitein (manufactured by Organic 
Technologies and obtained from NIH). The soy isoflavone mix-
ture was dissolved in dimethyl sulfoxide (DMSO) and mixed 
with sesame seed oil at a 1:20 ratio just before treatment to 
facilitate gavage and avoid irritation of the esophagus by DMSO 
(10–12).
lung irradiation
Radiation was delivered to the whole lung of anesthetized mice 
positioned in jigs under a 6.4-mm lead shield with cut outs to per-
mit selective lung irradiation, as previously detailed (11). Photon 
irradiation was performed at 10  Gy with a Siemens Stabilipan 
X-ray set operated at 250 kV, 15 mA with 1 mm copper filtration 
at a distance of 47.5 cm from the target (14). The dose rate was 
101 cGy/min, and half value layer was 2 mm Cu.
experimental Design
Mice were pretreated with oral soy isoflavones each day for 3 days 
at a dose of 5 mg/day (250 mg/kg), followed by lung irradiation 
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at 10 Gy. Soy treatment was continued for 5 more days at 5 mg/
day, and then a lower soy dose of 1 mg/day was given daily 5 days 
a week for up to 4 weeks, as previously detailed (11). In control 
mice and mice receiving irradiation alone, mice were treated with 
DMSO/sesame seed oil vehicle.
analysis of MDsc subsets and 
intracellular arg-1 by Flow cytometry
After bronchoalveolar lavage, the lungs were processed for single-
cell suspension, and cells were immunostained using CD45-APC, 
CD11b-PE, Ly6C-PE-Cy7, and Ly6G-PE-Cy5.5 fluorescent 
antibodies (Abs), as previously described (14). After surface 
antigen staining, cells were fixed with 4% paraformaldehyde 
for intracellular Arg-1 staining (BD Biosciences, San Jose, CA, 
USA) followed by anti-IgG1-FITC. Cells were analyzed by flow 
cytometry using a BD LSR II flow cytometer (BD Biosciences, 
San Jose, CA, USA), followed by analysis on FlowJo v10 software 
(Tree Star Inc., Ashland, OR, USA) (14).
Western Blot analysis
Protein lysates were prepared from the lungs using a gentleMACS 
tissue dissociator (Miltenyi Biotec, San Diego, CA, USA). Total 
lung protein extracts (90 µg) were loaded and separated on 10% 
sodium dodecyl sulfate polyacrylamide gel electrophoresis and 
transferred to Whatman membranes. Membranes were incu-
bated with anti-Arg-1 and anti-NF-κB p65 Abs (eBioscience) 
followed by horseradish peroxidase-conjugated secondary Ab. 
Membranes were reprobed with anti-β-actin Ab as a loading 
control, visualized by SuperSignal West Pico Chemiluminescent 
Substrate (ThermoFischer Scientific, Waltham, MA, USA) and 
captured on a Fotodyne imaging system (Fotodyne Inc., Hartland, 
WI, USA) (14).
immunohistochemistry (ihc)
The lungs were intratracheally instilled with 10% buffered 
formalin and resected, embedded in paraffin, and sectioned. 
Sections were incubated with anti-Arg-1 Ab following by 
biotinylated secondary Abs. Staining was amplified with the 
avidin-biotin immunoperoxidase technique, and slides were 
examined using Nikon E800 microscope (Nikon Inc., Melville, 
NY, USA) (14).
cytokine analysis by elisa
Lung homogenates were prepared using a gentleMACS tissue dis-
sociator (Miltenyi Biotec, San Diego, CA, USA). Lung homogen-
ates were assayed for interleukin (IL)-6, tumor necrosis factor 
(TNF)-α, IL-1β, and interferon (IFN)-γ using the respective 
Ready-SET-GO ELISA kits (eBioscience, San Diego, CA, USA) 
according to manufacturer’s instructions.
statistical analysis
Comparisons between means of two treatment groups were 
analyzed by two-tailed unpaired Student’s t-test. Data were reana-
lyzed using ANOVA followed by Tukey’s Multiple Comparison 
Test, and the results confirmed the t-test significance values. 
A p value of <0.05 was considered statistically significant.
resUlTs
arg-1 expression in cD11b+ Myeloid 
Populations is sustained by soy 
isoflavones at 1 Week Postradiation
To address early molecular events modulated by soy isoflavones 
in the inflammatory response caused by radiation injury in the 
lungs, the expression of intracellular Arg-1 in lung CD11b+ 
myeloid cells was analyzed by flow cytometry at an early time 
point of 1 week after radiation (Figure 1A). Treatment of mice 
with lung irradiation and/or soy isoflavones did not affect 
the percentage of CD11b+ cells present in the lungs at 1 week 
postradiation, which represent about 35% of lung leukocytes 
(Figure  1B). However, radiation significantly decreased the 
percentage of Arg-1+ cells within the CD11b+ myeloid compart-
ment in lungs compared to control (p < 0.05) (Figure 1C). Arg-
1+ myeloid cells were sustained in lungs treated with radiation 
and soy isoflavones with a significant increase in CD11b+Arg-1+ 
cells compared to radiation (p < 0.01) (Figure 1C). These find-
ings were confirmed by western blot analysis of Arg-1 overall 
expression in lung tissue lysates at 1 week after radiation, show-
ing a significant decrease induced by radiation relative to control 
(p <  0.001) (Figures  1D,E). The addition of soy isoflavones 
resulted in higher Arg-1 levels compared to radiation alone 
(p < 0.01) (Figures 1D,E).
expression of arg-1 in cD11b+ MDscs 
subsets in lung Tissue
To further interrogate the specific CD11b+ myeloid subsets in 
the lungs that are augmented by radiation and soy isoflavones 
at 1  week after radiation, intracellular expression of Arg-1 in 
MDSCs subsets was examined by flow cytometry. CD11b+ cell 
subsets were gated based on their differential expression of Ly6C 
and Ly6G to analyze mo-MDSCs (CD11b+Ly6C+Ly6G−) and 
granulocytic-MDSCs (CD11b+Ly6ClowLy6G+) (Figure 2A). The 
CD11b+Ly6ClowLy6G+ granulocytic-MDSCs (gr-MDSC) were 
of particular interest as this subset expressed the majority of 
Arg-1 in the lungs (70.07 ± 2.14% in control mice) (Figure 2B, 
arrow).
Further analysis focused on the CD11b+Ly6ClowLy6G+ gr-
MDSC subset and showed that radiation and/or soy isoflavones 
treatment did not significantly affect their overall frequency 
(21–24% of CD11b+ cells) in the lung at 1  week postradiation 
compared to control (p > 0.05, Figure 2C). However, radiation 
significantly decreased the percentage of Arg-1-expressing 
cells within the CD11b+Ly6ClowLy6G+ gr-MDSCs subset from 
74 ±  2.14% to 56.83 ±  2.20% compared to control (p <  0.01) 
(Figure 2C). Expression of Arg-1+ was significantly restored to 
73.33 ± 1.41% in the CD11b+Ly6ClowLy6G+ gr-MDSC subset by 
treatment with radiation + soy isoflavones compared to radiation 
alone (p < 0.05), to levels comparable of control or soy-treated 
lungs (Figure 2C). Analysis of the gr-MDSC subset at a later time 
point of 4 weeks after radiation showed a significant decrease in 
this subset caused by radiation compared to control (p < 0.05) 
(Figure 2D). A trend to decreased Arg-1 expression in gr-MDSC 
subset was also observed by radiation but was not significant 
FigUre 1 | effect of soy isoflavones on intracellular arginase-1 (arg-1) levels in cD11b+ leukocytes in the lungs at 1 week postradiation. (a–c) 
Single-cell suspensions obtained from the lungs were analyzed by flow cytometry. (a) Gating strategy for CD11b+ and CD11b+Arg1+ cells. CD11b+ myeloid cells 
were gated within the CD45+ lung leukocytes. Intracellular Arg-1 cells were gated within the CD11b+ myeloid cells. (B) Analysis of CD45+CD11b+ leukocytes in the 
lungs from control (Con) and mice treated with soy (Soy), radiation (Rad), or radiation + soy (R + S). Percentages of CD11b+ cells within CD45+ cells are presented 
as mean ± SEM (n = 3 mice/group). (c) Intracellular Arg-1 expression in CD11b+ lung myeloid cells. Percentages of CD11b+Arg-1+ cells within CD45+ leukocytes 
are presented as mean ± SEM (n = 3 mice/group). *p < 0.05 for radiation compared to control, and **p < 0.01 or R + S compared to Rad alone. (D,e) Western blot 
analysis of Arg-1 on lung lysates obtained at 1 week after radiation. Radiation caused a significant decrease in Arg-1, but Arg-1 levels in R + S-treated lungs were 
comparable to those of Con or Soy lungs as confirmed in (e) by quantification of band intensities using ImageJ (NIH) densitometry analysis. The data are presented 
as mean ± SEM (n = 2 mice/group). ***p < 0.001 for radiation compared to control, and **p < 0.01 for R + S compared to radiation alone.
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compared to control, which could reflect fluctuations in response 
to radiation at different time points. At 4 weeks after radiation, 
the percentages of CD11b+Ly6ClowLy6G+ gr-MDSC and the levels 
of Arg-1 expression were not altered in mice lungs treated with 
radiation +  soy isoflavones and were not significantly different 
from control (p > 0.05) (Figure 2D).
Analysis of the CD11b+Ly6C+Ly6G− mo-MDSC (Figure 2A, 
lower right quadrant) showed that this subset constitutes about 
17–20% of CD11b+ cells. The percentages of mo-MDSC were 
not significantly changed by treatment with radiation, soy, or 
radiation +  soy isoflavones compared to control mice at 1 or 
4 weeks after radiation (p > 0.05). This subset showed a very low 
expression of Arg-1 of only 6% in contrast to the 70% levels in 
gr-MDSC.
increase in arg-1+ cells by soy 
isoflavones in irradiated lung alveolar 
septa
Overall expression of Arg-1 in cells in lung tissues was analyzed 
by IHC staining at early and late time points of 1, 4, and 12 weeks 
after radiation. At early and late time points after radiation, an 
increase in Arg-1+ cells was seen in alveolar septa from the 
lungs treated with radiation  +  soy isoflavones compared to 
control or radiation alone (Figure 3; Table 1). This persistent 
increase was observed evenly in cells in alveolar septa including 
large alveolar and interstitial macrophages as well as in smaller 
inflammatory cells. Consistent low levels of Arg-1+ cells were 
observed in the alveolar septa of lungs treated with radiation, 
FigUre 2 | intracellular arginase-1 (arg-1) expression of myeloid-derived suppressor cells (MDscs) subsets at 1 and 4 weeks postradiation by flow 
cytometry analysis. Single-cell suspensions isolated from the lungs were stained with anti-CD45, anti-CD11b, anti-Ly6C, and anti-Ly6G fluorescent antibodies to 
analyze CD11b+ myeloid subsets within CD45+ leukocyte populations by flow cytometry. (a) Gating of MDSCs subsets based on the expression of Ly6C and Ly6G 
within the CD45+CD11b+ cell population. (B) Gating of intracellular Arg-1+ within the CD11b+Ly6ClowLy6G+ granulocytic MDSC (arrows). (c) Analysis of 
CD11b+Ly6ClowLy6G+ granulocytic MDSC (gr-MDSC) subset and Arg1 expression at 1 week after radiation. Percentages of CD11b+Ly6ClowLy6G+ gr-MDSCs within 
the CD11b+ gated cells and percentages of Arg-1+ cells within CD11b+Ly6ClowLy6G+ cells are shown for lungs from control (Con) mice and mice treated with soy 
(Soy), radiation (Rad), or radiation + soy (R + S). (D) Analysis of CD11b+Ly6ClowLy6G+ gr-MDSC subset and their Arg1 expression at 4 weeks after radiation following 
treatment with Soy, Rad, and R + S. All data are presented as mean ± SEM (n = 3 mice/group). Significant data are labeled as **p < 0.01 or *p < 0.05 for radiation 
compared to Con or R + S compared to Rad alone.
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compared to radiation +  soy isoflavones (Figure  3; Table  1). 
Control lungs showed evenly distributed Arg-1+ cells (Figure 3; 
Table 1).
soy isoflavones inhibit radiation-induced 
nF-κB p65 in lung Tissue
Nuclear factor κB activation can be indirectly measured by the 
release of NF-κB p65 subunit from IκB. Therefore, the effect of 
radiation and soy isoflavones on the expression of NF-κB p65 
subunit in lung lysate was analyzed by western blot. Radiation 
induced an increase in NF-κB p65 subunit protein levels at 1, 8, 
and 12 weeks postradiation compared to control and soy alone 
(Figure 4). The addition of soy isoflavones to radiation treatment 
consistently inhibited the expression of NF-κB p65 at each time 
point compared to the levels observed with radiation alone. These 
data were consistently reproduced in two to three separate experi-
ments using either individual lungs from treated mice or lungs 
pooled from three mice per groups.
TaBle 1 | histological scoring of arginase-1 (arg-1)+ cells stained by 
immunohistochemistry in lungs.
control radiation rad + soy
1 week + + +++
4 weeks + + +++
12 weeks ++ ++ ++++
Histological scoring for expression of Arg-1 shown in Figure 3 in the lung tissues 
treated with radiation and soy isoflavones at 1, 4, and 12 weeks after radiation using a 
scale from moderate (+), strong (++), very strong (+++), and heavy (++++).
FigUre 3 | Overall expression of arginase-1 (arg-1) in the lung tissue treated with radiation and soy isoflavones (rad + soy) at 1, 4, and 12 weeks 
postradiation. Lungs tissue sections obtained from control (Con) mice and mice treated with radiation (Rad) or Rad + Soy at 1, 4, and 12 weeks after radiation 
were stained for Arg-1 by immunohistochemistry. An increase in staining of Arg-1+ cells was seen in the lungs treated with Rad + Soy, compared to Rad, which 
persisted at 12 weeks. All magnifications are at 40×.
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effect of soy isoflavones on radiation-
induced cytokines
We showed that soy isoflavones inhibited expression of the NF-κB 
p65 subunit induced by radiation in lungs, and therefore, this 
could alter the transcription of inflammatory cytokines implicated 
in radiation-induced pulmonary injury (23, 24). IL-6, TNF-α, 
IL-1β, and IFN-γ pro-inflammatory cytokine levels were assessed 
at early time points of 4 h, 24 h, 1 week, and late time points of 4 
and 12 weeks after radiation (Figure 5A). Compared to control, 
radiation induced a significant increase of IL-6 already seen at 
4 h that remained high until 4 weeks after radiation (p < 0.001). 
Soy isoflavones significantly inhibited IL-6 induced by radiation 
at 4 weeks (p < 0.01) (Figure 5A). TNF-α levels in the lungs were 
initially increased by radiation early at 4 h (p < 0.01) but not by 
combined radiation and soy isoflavones (p < 0.01) (Figure 5A). 
At later time points after radiation, the levels of TNF-α remained 
low but with a further decrease mediated by soy isoflavones at 4 
and 12 weeks (p < 0.01). Significant increases in IL-1β caused by 
radiation, at late time points of 4 and 12 weeks, were inhibited 
by soy isoflavones (p <  0.01) (Figure  5A). Radiation and soy 
isoflavones triggered a higher level of IL-1β early at 4 and 24 h 
(p <  0.01), but these levels dropped at 1 week. Fluctuations in 
IFN-γ levels were observed with higher levels by radiation and 
soy isoflavones at 24 h; however, by 4 and 12 weeks, the combined 
treatment caused significant decreases in IFN-γ compared to 
radiation (p <  0.01) (Figure  5A). Treatment of mice with soy 
isoflavones alone did not significantly affect the levels of these 
pro-inflammatory cytokines in the lungs (data not shown).
Studies of IL-4, IL-10, IL-13, and IL-15 anti-inflammatory 
cytokines showed increasing trends over time in the lungs 
treated by radiation alone or combined with soy isoflavones 
(Figure 5B). At a late time point of 8 weeks, a further increase 
was observed following radiation combined with soy isoflavones 
that was significant for IL-15 (p < 0.05) (Figure 5B). Treatment 
with soy isoflavones alone showed a trend toward increasing 
anti-inflammatory cytokines by 4 weeks of treatment (data not 
shown).
DiscUssiOn
The pathology of lung injury following thoracic radiation is trig-
gered by acute inflammation and promoted by pro-inflammatory 
cytokines that sets off a cascade of events akin to an aberrant 
wound healing response, with no resolution of inflammation 
but rather progression to fibrosis (6, 25, 26). We have previously 
FigUre 4 | soy isoflavones inhibit radiation-induced increase of nuclear factor κB (nF-κB) p65 subunit levels in lung tissue. Western blot analysis of 
NF-κB p65 using whole lung tissue lysates obtained from control (Con) mice and mice treated with soy isoflavones (Soy), radiation (Rad), or radiation + soy (R + S) 
at 1, 8, and 12 weeks after radiation. These data are representative of data reproduced in additional mice and in separate experiments.
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reported that soy isoflavones inhibited the infiltration and 
activation of macrophages and neutrophils in irradiated lungs 
in naïve mice (14). However, soy isoflavones may also promote 
MDSCs to suppress inflammatory pathways induced by radia-
tion injury. Expression of the enzyme Arg-1 by MDSC plays a 
key role in dampening inflammation (15, 17, 27). The effect of 
soy isoflavones on MDSC subsets in the lungs in association with 
Arg-1 expression was studied during the early phase of radiation-
induced inflammation.
Flow cytometry analysis of CD11b+ myeloid cells revealed 
that the cells expressing Arg-1 were significantly decreased 
by radiation but preserved by soy isoflavones combined with 
radiation at an early time point of 1  week after radiation. 
Delineation of CD11b subsets based on Ly6C and Ly6G showed 
that intracellular Arg-1 was expressed in only about 6% of 
CD11b+Ly6C+Ly6G− mo-MDSCs with no effect of soy and 
radiation. However, intracellular Arg-1 was predominant in 
CD11b+Ly6ClowLy6G+gr-MDSCs with 70% expression and was 
reduced by radiation but preserved by soy isoflavones. This 
trend was also observed at 4  weeks after radiation, suggesting 
a hypothetical role for gr-MDSCs expressing Arg-1 as an early 
event in the modulation of radiation-induced inflammation by 
soy isoflavones.
Histological studies confirmed that radiation caused an over-
all decrease in the expression of Arg-1 in cells of lung alveolar 
septa as early as 1 week after radiation, whereas treatment with 
radiation and soy isoflavones increased Arg-1 expression. This 
increase in Arg1+ cells observed in the lungs treated with radia-
tion combined with soy isoflavones persisted for up to 12 weeks 
after radiation, suggesting modulation of molecular mediators 
of inflammation by soy isoflavones at both early and late time 
points after radiation. Expression of Arg-1 may be not only due 
to gr-MDSCs but also due to additional myeloid inflammatory 
cells. We have previously published that following radiation and 
soy treatment, alveolar macrophages in lung tissue express high 
levels of Arg-1 at a late time point of 18 weeks, which could be 
due to the promotion of M2 macrophages (14).
Elevated Arg-1 may suppress inflammatory pathways by 
competitively inhibiting inducible nitric oxide synthase (iNOS) 
and reducing ROS (22). Arg-1 expression by MDSCs could 
interfere with signaling events caused by ROS induced by radia-
tion that are involved in NF-κB activation and transcription of 
FigUre 5 | soy isoflavones modulation of cytokine production induced by radiation in lung tissue. Cytokine levels were measured by ELISA in lung 
homogenates obtained from control mice (Con) and from treated mice at 4 h, 24 h, and 1, 4, 8, or 12 weeks following radiation (Rad) or radiation + soy isoflavones 
(Rad + Soy). (a) Kinetics of interleukin (IL)-6, tumor necrosis factor-α, IL-1β, and interferon-γ pro-inflammatory cytokines. (B) Kinetics of IL-4, IL-10, IL-13, and IL-15 
anti-inflammatory cytokines. The data are presented as the mean ± SEM (n = 4–9 mice/group). *p < 0.05, **p < 0.01, and ***p < 0.001 when radiation is compared 
to control or when Rad + Soy is compared to Rad alone.
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pro-inflammatory cytokines (22, 28). Thoracic irradiation caused 
an increase in NF-κB p65 subunit levels as early as 1 week after 
radiation and was still observed by 12  weeks after radiation. 
The durable increase in NF-κB p65 subunit in irradiated lungs 
is reflective of continuous activation of molecular mediators 
involved in tissue inflammation triggered by radiation. However, 
addition of soy isoflavone treatment to radiation consistently 
inhibited NF-κB p65 levels at early and late time points after 
radiation.
Nuclear factor κB is essential for the transcription of inflam-
matory cytokines implicated in radiation-induced pneumonitis 
and fibrosis (25). We previously reported that soy isoflavones 
inhibit radiation-induced IL-6, TNF-α, IL-1β, and IFN-γ pro-
inflammatory cytokines at late time points after radiation (11). 
These studies were further expanded to test pro-inflammatory 
and anti-inflammatory cytokines at early and late time points 
after radiation. Despite fluctuations in cytokine levels, soy iso-
flavones consistently inhibited IL-6, TNF-α, IL-1β, and IFN-γ 
pro-inflammatory cytokines at late time points of 4 to 12 weeks 
after radiation. Soy isoflavones caused a trend toward increasing 
levels of anti-inflammatory cytokines that was more significant 
with IL-15 but still noted with IL-4, IL-10, and IL-13 TH2 type 
cytokines. An anti-inflammatory role has been suggested for 
IL-15 cytokine to control TH1 immune responses in Crohn’s 
disease (29). The role of IL-15 in alleviation of radiation-induced 
inflammation by soy isoflavones warrants further investigation.
Our previous studies demonstrated that soy isoflavones 
inhibited the radiation-induced activation and infiltration of 
macrophages and neutrophils in lung tissues (14). Radiation 
induced a pro-inflammatory M1 macrophage phenotype, 
whereas addition of soy isoflavones caused a polarization to an 
anti-inflammatory M2 macrophage phenotype with increased 
levels of Arg-1 and decreased NOS2, which promote tissue repair 
(14). Our current study suggests that Arg-1-mediated resolution 
of inflammation could also occur during the early acute phase 
of radiation-induced inflammation. Interestingly, at late time 
points, soy isoflavones also protected immunoregulatory inter-
stitial macrophages, which were decreased by radiation (14). Our 
findings are in agreement with other studies reporting that Arg-1 
could attenuate the function of iNOS, inhibit NF-κB activation 
and inflammatory cytokines in vitro, and decrease macrophage 
infiltration and inflammation in vivo in a rabbit model of athero-
sclerosis (22). MDSCs played a critical role in the resolution of 
acute inflammation and tissue repair caused by spinal cord injury 
(30) and were found to modulate macrophage activation toward 
an immunosuppressive phenotype through Arg-1 (31). Whether 
early protection of Arg-1+ MDSC by soy isoflavones plays a role 
in altering molecular pathways involved in radiation-induced 
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inflammation such as NF-κB activation and pro-inflammatory 
cytokine production remains to be established.
In summary, our preclinical study suggests that a radiopro-
tective mechanism of soy isoflavones may involve, among other 
mechanisms, the promotion of gr-MDSCs that express Arg-1, 
which could play a role in downregulation of inflammation and 
ultimately lung radioprotection.
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